IMiG-MRI, the joint venture between Intermagnetics General ofLatham, NY, and Surrey Medical Imaging Systems of Surrey, U.K.,has received 510(k) clearance for its IMiG-MRI 0.15-tesla permanent-magnetscanner (SCAN 7/3/96). The Food and Drug
IMiG-MRI, the joint venture between Intermagnetics General ofLatham, NY, and Surrey Medical Imaging Systems of Surrey, U.K.,has received 510(k) clearance for its IMiG-MRI 0.15-tesla permanent-magnetscanner (SCAN 7/3/96). The Food and Drug Administration's actionwill enable IMiG-MRI to begin sales of the scanner in the U.S.as well as in several Asian countries, which have effectivelymade FDA clearance a requirement for marketing, according to IMiG-MRIgeneral manager Paul Domigan.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.